Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-19T10:51:26.955Z Has data issue: false hasContentIssue false

Gender Differences In The Therapeutic Evolution Of Major Depression during COVID-19 Pandemic

Published online by Cambridge University Press:  19 July 2023

C. Navarro-Guzmán
Affiliation:
University of the Balearic Islands, Palma
A. Aguilar-Latorre*
Affiliation:
Institute for Health Research Aragón (IIS Aragón), Zaragoza, Spain
A. García
Affiliation:
University of the Balearic Islands, Palma
M. Zamrik Vila
Affiliation:
University of the Balearic Islands, Palma
A. M. Yáñez
Affiliation:
University of the Balearic Islands, Palma
M. Gili-Planas
Affiliation:
University of the Balearic Islands, Palma
M. Garcia-Toro
Affiliation:
University of the Balearic Islands, Palma
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The COVID-19 pandemic has posed an enormous challenge to the mental health of the population with probable differentiated profiles for men and women, although not all studies are consistent. While women are likely to have endured greater loads of stress associated with an increased incidence of mental disorders such as depression, men have been able to abuse alcohol and other drugs more, in addition to complying with prevention recommendations to a lesser extent. As soon as the COVID pandemic began, we began a clinical trial to enhance first-line treatments with three complementary interventions with patients with Major Depression (MD), which has allowed us to analyze differences in response according to gender.

Objectives

As a secondary analysis of a clinical trial, the aim of the current study was to address the relative different efficacy between genders of three psychotherapeutic approaches in the context of MD.

Methods

This study was a secondary analysis of a pragmatic parallel randomized controlled clinical trial that was composed of three arms (Minimal Lifestyle Intervention, Mindfulness-Based Cognitive Therapy, and Lifestyle Modification Program). We recruited 94 individuals (24 men and 70 women) from the Primary Healthcare Centers of the Balearic Islands region in Spain who were currently experiencing an episode of MD. Descriptive and univariate analyses were used to examine between-group differences in sociodemographic and clinical data between the two genders. General Linear Modelling (specifically, repeated measures ANOVA) was performed to compare the effect of gender on the evolution of depressive symptoms (measured by BDI-II).

Results

Significant between-group differences were observed for the evolution of depressive symptoms after controlling for the intervention group and age. These results suggested that being a woman was significantly related to a worse evolution of depressive symptoms. This association implies a large effect size.

Conclusions

The COVID 19 pandemic has not only been able to predispose women to Depression to a greater extent, but it is also possible that it has negatively conditioned their response to antidepressant therapies compared to men. However, our data suggest the possibility that greater psychological support could help prevent this situation.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.